Even the Giants Have to Wait in Line
Behind it are the AI labs. Two of the leading frontier AI companies are reportedly preparing 2026 listings and positioning themselves behind SpaceX. One appears to have moved first with a confidential filing. The other seems willing to wait, likely giving itself room to price against whatever the earlier deals establish. Together, they could be seeking well over $200 billion in proceeds from the same broad pool of capital, inside the same general window. That is where the real constraint starts to show. IPO timing is never chosen in isolation. It is chosen relative to every other company asking the market for money at the same time.

In the next few weeks, SpaceX is expected to attempt the largest IPO in history.
Behind it, two of the largest AI listings ever are lining up. Three of the biggest companies private markets have produced are all moving toward public markets inside roughly four months.
That alone would make this an unusual window. What makes it more interesting is that they cannot all go at once.

The Queue Matters
SpaceX appears set to go first.
The S-1 is public. The roadshow is expected in early June, with pricing around June 11 and first trade around June 12 on Nasdaq under SPCX. Reports have put the target at roughly $75 billion raised at a $1.75 trillion valuation. If it lands there, it would be the largest IPO in history.
Behind it are the AI labs. Two of the leading frontier AI companies are reportedly preparing 2026 listings and positioning themselves behind SpaceX. One appears to have moved first with a confidential filing. The other seems willing to wait, likely giving itself room to price against whatever the earlier deals establish. Together, they could be seeking well over $200 billion in proceeds from the same broad pool of capital, inside the same general window.
That is where the real constraint starts to show. IPO timing is never chosen in isolation. It is chosen relative to every other company asking the market for money at the same time.

Why the Order Matters
Capital is deep, but it is not infinite.
When a company like SpaceX raises $75 billion, that money has to come from somewhere. It comes from institutional allocations, fund rebalances, crossover capital, and retail demand. A deal of that size does not just price itself and disappear. It absorbs liquidity, attention, and risk appetite.
The company behind it is not entering the same market. It is entering a market that has just committed enormous capital to something else.
That can affect demand, sentiment, and how much room the next deal has to build momentum. This is why sequencing becomes a strategic question rather than a simple scheduling one. A company that lists immediately after a massive deal risks entering a market that is still digesting the prior one, which can mean weaker pricing, less enthusiasm, or a more fragile first few days of trading.
Even the most sought-after companies in the world have to think carefully about where they stand in that queue.
The issue is not quality. It is capacity. There is only so much room at the front of the line, even for companies of this size.
What That Means for Everyone Else
If the biggest private companies in the world have to manage their place in the queue, it is worth asking what that means for everyone outside it.
The IPO is still a gated event. There is a roadshow the public does not attend. There is an allocation process most retail investors never meaningfully access. There is an ordering of the market where institutions stand at the front by default. For most people, the IPO is not early access. It is the first moment they are allowed in, after the earlier rounds are already closed and the price has already been shaped by participants who got there first.
That is one reason the public market increasingly feels late.
By the time the listing arrives, the company may already be mature, heavily funded, and widely recognized. The queue determines who gets in before that moment and who waits until the public debut.
Most people cannot change the queue itself. The more realistic question is whether they still need to stand in it.

Where Tessera Fits
That is the gap Tessera was built around.
T-SpaceX has been live since February 2026. It provides tokenized economic exposure linked to SpaceX’s pre-IPO valuation through a loan participation structure held via a Cayman SPC and settled on Solana.
The structure does not remove risk. The value still moves with the same company-specific events, the same market sentiment, and the same pressures a crowded IPO window can create. It can fall. It can go to zero.
What it does change is timing. Instead of waiting for an allocation most people were unlikely to receive, the structure gives users a way to take a position earlier, on-chain, while the company is still in the private phase and before the public queue fully takes over.
That matters more in a window like this. When three of the largest private-market names in the world are all moving toward public listings in close succession, access becomes even more about timing. It is not just whether you like the company. It is where you are allowed to stand when the market begins to price it.
There are two more names behind SpaceX in that line. One of them is where the focus turns next.
High risk. DYOR. Not financial advice. tessera.pe/terms
